期刊文献+

白念珠菌对唑类抗真菌药物耐药的研究进展 被引量:7

原文传递
导出
摘要 近年来,随着广谱抗菌药物、激素以及免疫抑制剂等药物的大量使用,各种介入治疗、器官移植等技术的广泛开展,真菌感染的患者不断增多。白念珠菌是目前临床常见的条件致病真菌之一。患者在机体免疫力低下时容易感染,可导致念珠菌阴道炎、念珠菌血症、鹅口疮等疾病。伴随唑类抗真菌药物的应用,临床出现越来越多耐唑类抗真菌药物的菌株,其中唑类抗真菌药物的靶酶编码基因ERGll的突变和过度表达是白念珠菌产生耐药性的重要原因,已成为近年来国内外学者研究的热点。现就此项研究进展做一综述。
出处 《中华传染病杂志》 CAS CSCD 北大核心 2013年第5期314-316,共3页 Chinese Journal of Infectious Diseases
基金 安徽省卫生厅基金项目(2008A001)
  • 相关文献

参考文献29

  • 1窦红涛,朱任媛,王瑶,刘娟,谢秀丽,徐英春,陈民钧.1472株酵母菌的菌株鉴定与药敏分析[J].中华医院感染学杂志,2010,20(13):1978-1979. 被引量:10
  • 2Podust LM, Poulos TL,Waterman MR. Crystal structure ofcytochrome P450 14alpha-sterol demethylase(CYP51) fromMycobacteriam tuberculosis in complex with azole inhibitors.Proc Natl Acad Sci USA, 2001,98:3068-3073.
  • 3Marichal P, Koymans L, Willemsens S, et al. Contributionof mutations in the cytochrome P450 14alpha-demethylase(Ergllp, Cyp51p) to azole resistance in Candida albicans.Microbiology, 1999,145 = 2701-2713.
  • 4王丽,惠艳,张丽娟,张巧巧,邓淑文,帕丽达·阿布利孜,王慧.艾滋病患者白念珠菌ERG11基因突变的研究[J].中华皮肤科杂志,2012,45(1):32-34. 被引量:4
  • 5项明洁,倪培华,刘锦燕,张华,陈华,倪语星.ERG11基因突变与白念珠菌对氟康唑耐药性的初步研究[J].检验医学,2009,24(12):856-860. 被引量:6
  • 6Sanglard D, Ischer F,Koymans L, et al. Amino acidsubstitutions in the cytochrome P-450 lanosterol 14alpha-demethylase( CYP51A1) from azole-resistant Candidaalbicans clinical isolates contribute to resistance to azoleantifungal agents. Antimicrob Agents Chemother, 1998,42:241-253.
  • 7贺志彬,廖万清.白念珠菌氟康唑耐药的分子生物学进展[J].中华临床医药杂志(北京),2003,4(19):34-39. 被引量:2
  • 8White TC. The presence of an R467K amino acidsubstitution and loss of allelic variation correlate with anazole-resistant ianosterol 14alpha demethylase in Candidaalbicans. Antimicrob Agents Chemother, 1997,41:1488-1494.
  • 9Franz R, Kelly SL,Lamb DC, et al. Multiple molecularmechanisms contribute to a stepwise development offluconazole resistance in clinical Candida albicans strains.Antimicrob Agents Chemother, 1998, 42:3065-3072.
  • 10Aoyama Y. Kudo M,Asai K,et al. Emergence offluconazole-resistant sterol 14-demethylase P450(CYP51) inCandida albicans is a model demonstrating the diversificationmechanism of P450. Arch Biochem Biophys, 2000,379:170-171.

二级参考文献28

  • 1徐永豪,李春阳.耐唑类药白念珠菌ERG11基因点突变[J].中国真菌学杂志,2006,1(6):370-373. 被引量:8
  • 2黄静,张天托,朱家馨,周宇麒,刘慧.耐氟康唑白念珠菌ERG11基因突变的测序研究[J].中华检验医学杂志,2007,30(1):31-32. 被引量:3
  • 3项明洁,刘锦燕,张华,彭奕冰,倪语星.ERG11基因突变介导白假丝酵母菌对唑类药物耐药的研究进展[J].中华检验医学杂志,2007,30(1):100-102. 被引量:1
  • 4周辉,龙铁军.Erg11基因突变与白念珠菌对唑类药物耐药性的初步研究[J].中国感染与化疗杂志,2007,7(2):108-110. 被引量:7
  • 5王端礼,李若瑜,王晓红.孢子发生在真菌菌种鉴定中的作用[J].中国真菌学杂志,2007,2(2):65-67. 被引量:5
  • 6National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts[ S]. M27-A2 ,NCCLS ,2002.
  • 7Perea S, Patterson TF. Antifungal resistance in pathogenic fungi[ J ]. Clin Infect Dis, 2002, 35 (9) : 1073-1080.
  • 8Perea S, Lopez-Ribot JL, Kirkpatrick WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficieney virus-infected patients [ J ]. Antimicrob Agents Chemother, 2001,45 (10) : 2676-2684.
  • 9Marichal P,Koymans L,Willemsens S, et al. Contribution of mutations in the cytochrome P450 14alpha- demethylase ( Ergl 1 p, Cyp51 p) to azole resistance in Candida albicans [ J ]. Microbiology, 1999, 145 (Pt10) :2701-2713.
  • 10Sanglard D, Ischer F, Koymans L, et al. Amino acid substitutions in the cytochrorne P-450 lanosterol 14 alpha-demethylase ( CYP51A1 ) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents [ J ]. Antimicrob Agents Chemother, 1998,42 (2) :241-253.

共引文献17

同被引文献38

  • 1王应斌,王宏,郭辉玉,赵永忠,罗深秋.白假丝酵母ERG11基因突变分析[J].第一军医大学学报,2005,25(11):1390-1393. 被引量:9
  • 2徐永豪,李春阳.耐唑类药白念珠菌ERG11基因点突变[J].中国真菌学杂志,2006,1(6):370-373. 被引量:8
  • 3路晓钦,黎莉华,周丽,刘利.白假丝酵母菌感染分布及耐药性分析[J].中国感染控制杂志,2007,6(6):419-421. 被引量:16
  • 4Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit[J]. Int J Antimicrob Agent,2000,15(2):83-90.
  • 5Lrpez Moral L,Tiraboschi IN, Schijman M, et al. Fungemia in hospitals of the City of Buenos Aires Argentina[J]. Rev Iberoam Micol,2012,29(4): 144-149.
  • 6Kremery V, Barnes AJ. Non-albicans Candida spp. causing fnngaemia: pathogenicity and antifungal resistance[J]. J Hosp Infect,2002,50(11):243-260.
  • 7Rogers PD, Vermitsky JP, Edlind TD, et al. Proteomic analysis of experimentally induced azole resistance in Candida glabrata[J]. J Antimicrob Chemother,2006,58(6):434-438.
  • 8Posteraro B, Sanguinetti M, Fiori B, et al. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes[J]. J Antimicrob Chemother,2006,58(7):458-461.
  • 9Nett JE, Sanchez H, Cain MT, et al. Genetic basis of Candidabiofilm resistance due to Drug-sequestering matrix gluean[J]. J Infect Dis,2010,202(12): 171-175.
  • 10Moran C, Grussemeyer CA, Spalding JR, et ai.Candida albi- cans and non-albicans bloodstream infections in adult and pe diatric patients:comparison of mortality and costs[J].Pediatr Infect Dis J,2009,28(5):433 435.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部